Taking medicines from bench to bedside
The ongoing review of the EU Pharmaceutical Legislation is looking at recalibrating IP incentives. Intellectual Property fuels medical innovations from the research bench to the patient’s bedside.
Stay updated with breaking news from Therapeutics Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The ongoing review of the EU Pharmaceutical Legislation is looking at recalibrating IP incentives. Intellectual Property fuels medical innovations from the research bench to the patient’s bedside.
/PRNewswire/ -- The "Advances in Mitochondrial Disease Management" report has been added to ResearchAndMarkets.com's offering. This study identifies diverse...
Have you ever wondered how scientists delve into the intricate details of cellular behavior, unraveling the mysteries of life at a microscopic level? Flow cytometry is a ground-breaking technology that has transformed the field of biomedical research. What technological marvels paved the way for our invention?Flow cytometry was formed as a result of a fascinating
Operator: Hello, and welcome to 23andMe's Fiscal Year 2024 Second Quarter Financial Results Conference Call. As a reminder, this call is being recorded.
23andMe presented data from the now completed dose escalation phase, and pharmacokinetic / pharmacodynamic (PK/PD) cohorts at the Society for Immunotherapy of Cancer Annual Meeting 2023